These fund managers were still conducting research before the Spring Festival, preparing for the market after the holiday. Which companies did they visit?

① Before the Spring Festival, companies in the CSI Consumer 360 index received active research from multiple public funds; ② Companies in the Robot Concept, Autos Industry Chain, Software, and integrated circuit fields also received research from several public funds.

cls.cnJan 25 08:18

Anjoy Foods Group has submitted its prospectus, aiming for A+H shares, with Goldman Sachs and China International Capital Corporation as joint sponsors | A-share company listed in Hong Kong.

Ryanben CapitalJan 21 14:26

Market Movements | Home Appliances stocks in Hong Kong are active, HISENSE HA is up by 4%, and the National Development and Reform Commission has intensified the old-for-new subsidy policy.

Hong Kong stocks in the Home Appliances sector were active in the morning. As of the time of writing, HISENSE HA is up 4%, HAIER SMARTHOME is up 2%, and Midea Group Co., Ltd is up 1%.

Futu NewsJan 8 10:31

CES Hotspot Preview: Major companies like NVIDIA, AMD, Intel, and others release new products, with the market continuing to focus on AI, chips, and AR/VR.

① The CES exhibition will begin next week, and cutting-edge technologies such as AI, chips, and AR/VR will receive a lot of attention; ② Major companies such as NVIDIA, AMD, and Intel will hold a series of press conferences early next week; ③ Over a thousand Chinese companies will participate, accounting for more than 30% of the total exhibitors.

cls.cnJan 5 10:00

The competition is fierce! Musk once said that "Tirzepatide", which is more effective than semaglutide, will be launched in China. Who will dominate the weight loss drug market in 2025?

① Today, Eli Lilly and Co announced the official launch of tirzepatide in China, covering both type 2 diabetes and weight loss, and it is already available on some online platforms; ② Musk has claimed that tirzepatide is better than semaglutide, while the market is more focused on the pricing of tirzepatide and whether it will be included in medical insurance; ③ The competition in the GLP-1 sector will become even more intense in 2025, with Jiangsu Hengrui Pharmaceuticals, INNOVENT BIO, and Gan & Lee Pharmaceuticals receiving widespread attention.

cls.cnJan 2 16:20

Policy stimulus for 3C and home appliance demand release. Will the multiplier effect of the "trade-in" policy continue in 2025? | Year-end review.

In 2024, the implementation of the "national subsidy" policy for the exchange of old for new will effectively stimulate the demand for home appliances and Consumer Electronics. Market analysis suggests that related subsidies for the exchange of old for new are expected to continue next year, with mobile phones and more home improvement categories likely included, while the future policy-driven effects still remain to be observed.

cls.cnDec 29, 2024 23:17